Hydrogen Sulphide Is Involved in Testosterone Vascular Effect

European Urology

Volumn 56, Issue 2, 2009, Pages 378-384

  Bucci, Mariarosaria ^a   Mirone, Vincenzo ^b   Di Lorenzo, Annarita ^a   Vellecco, Valentina ^a   Roviezzo, Fiorentina ^a   Brancaleone, Vincenzo ^a   Ciro, Imbimbo ^b   Cirino, Giuseppe ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Clinica di Medicina Sessuale (CIRMS)   (Italy)

Author keywords

cyano L alanine; Cystathionine lyase; Hydrogen sulphide; L cysteine; Propargylglycine; Testosterone; Vascular reactivity

Indexed keywords

ALANINE DERIVATIVE; BETA CYANO ALANINE; BISULFITE; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; CYSTEINE; FAT; GLIBENCLAMIDE; HYDROGEN SULFIDE; PROPARGYLGLYCINE; TESTOSTERONE; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL REACTIVITY; CALIBRATION; CONNECTIVE TISSUE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FORCE TRANSDUCER; HORMONE ACTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STUDENT T TEST; THORACIC AORTA; VASODILATATION; WESTERN BLOTTING;

ANIMALS; HYDROGEN SULFIDE; MALE; RATS; RATS, WISTAR; TESTOSTERONE; VASODILATION;

EID: 67649443015     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.05.014     Document Type: Article

References (29)

1. English K.M., Mandour O., Steeds R.P., Diver M.J., Jones T.H., and Channer K.S. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J 21 (2000) 890-894
2. Hromadova M., Hacik T., Malatinsky E., and Riecansky I. Alteration of lipid metabolism in men with hypotestosteronemia. Horm Metabol Res 23 (1991) 392-394
3. Eckardstein A., and Wu F.C.W. Testosterone and atherosclerosis. Growth Horm & IGF Res 13 (2003) S72-S84
4. English K.M., Steeds R., Jones T.H., and Channer K.S. Testosterone and coronary heart disease: is there a link?. Q J Med 90 (1997) 787-791
5. Smith A.M., Jones R.D., and Channer K.S. The influence of sex hormones on pulmonary vascular reactivity: possible vasodilator therapies for the treatment of pulmonary hypertension. Curr Vasc Pharmacol 4 (2006) 9-15
6. Jones R.D., Nettleship J.E., Kapoor D., Jones H.T., and Channer K.S. Testosterone and atherosclerosis in aging men: purported association and clinical implications. Am J Cardiovasc Drugs 5 (2005) 141-154
7. Chou T.M., Sudhir K., Hutchison S.J., et al. Testosterone induces dilatation of canine coronary conductance and resistance arteries in vivo. Circulation 94 (1996) 2614-2619
8. Costarella C.E., Stallone J.N., Rutecki G.W., and Whittier F.C. Testosterone causes direct relaxation of rat thoracic aorta. J Pharm Exp Ther 277 (1996) 34-39
9. Perusquia M., Hernandez R., Morales M.A., Campos M.G., and Villalon M.G. Role of the endothelium in the vasodilating effect of progestins and androgens on the rat thoracic aorta. Gen Pharmacol 27 (1996) 181-185
10. Honda H., Unemoto T., and Kogo H. Different mechanisms for testosterone-induced relaxation of aorta between normotensive and spontaneously hypertensive rats. Hypertension 34 (1999) 1232-1236
11. 2+ entry mechanism of coronary vasoconstriction. Arterioscler Thromb Vasc Biol 19 (1999) 1034-1040
12. Tep-areenan P., Kendall D.A., and Randall M.D. Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels. Br J Pharmacol 135 (2002) 735-740
13. Levonen A.L., Lapatto R., Saksela M., and Raivio K.O. Human cystathionine gamma-lyase: developmental and in vitro expression of two isoforms. Biochem J 347 (2000) 291-295
14. Yap S., Naughten E.R., Wilcken B., Wilcken D.E., and Boers G.H. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta synthase deficiency: effects of homocysteine-lowering therapy. Semin Thromb Hemost 26 (2000) 335-340
15. Van der Molen E.F., Hiipakka M.J., van Lith-Zanders H., et al. Homocysteine metabolism in endothelial cells of a patient homozygous for cystathionine beta-synthase (CS) deficiency. Thromb Haemost 78 (1997) 827-833
16. 2S in rat tissues. Can J Physiol Pharmacol 81 (2003) 848-853
17. Hosoki R., Matsiki N., and Kimura H. The possible role of hydrogen sulphide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophysic Res Comun 237 (1997) 527-531
18. Yue P., Chatterjee K., Beale C., Poole-Wilson P.A., and Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation 91 (1995) 1154-1160
19. + channel activation. J Appl Physiol 91 (2001) 2742-2750
20. ATP channel opener. EMBO J 20 (2001) 6008-6016
21. Cheng Y., Ndisang J.F., Tang G., Cao K., and Wang R. Hydrogen sulphide-induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 287 (2004) H2316-H2323
22. Nelson M.T., and Quayle J.M. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268 (1995) C799-C822
23. Reed D.J. Cystathionine. Meth In Enzym 252 (1995) 92-102
24. Uren J.R., Ragin R., and Chaykovsky M. Modulation of cysteine metabolism in mice-effects of propargylglycine and L-cysteine-degrading enzymes. Bioche Pharmacol 27 (1978) 2807-2814
25. Stipanuk M.H., and Beck P.W. Characterization of the enzymatic capacity for cysteine desulphydration in liver and kidney of the rat. Biochem J 206 (1982) 267-277
26. Szabo C. Hydrogen sulphide and its therapeutic potential. Available at http://www.nature.com/nrd/journal/v6/n11/abs/nrd2425.html.
27. 2S) protects against regional myocardial ischemia-reperfusion injury. Evidence for a role of K ATP channels. Basic Res Cardiol 101 (2006) 53-60
28. 2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology 42 (2005) 539-548
29. Jones R.D., English K.M., Jones T.H., and Channer K.S. Testosterone-induced coronary vasodilatation occurs via non-genomic mechanism: evidence of a direct calcium antagonism action. Clin Sci (Lond) 107 (2004) 149-158